65 related articles for article (PubMed ID: 11965544)
1. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1.
Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP
Oncogene; 2002 Apr; 21(17):2713-20. PubMed ID: 11965544
[TBL] [Abstract][Full Text] [Related]
2. Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis.
Williams O; Hu L; Huang W; Patel P; Bartom ET; Bei L; Hjort E; Hijiya C; Eklund EA
J Biol Chem; 2023 Jul; 299(7):104867. PubMed ID: 37247756
[TBL] [Abstract][Full Text] [Related]
3. RAB13 mRNA compartmentalisation spatially orients tissue morphogenesis.
Costa G; Bradbury JJ; Tarannum N; Herbert SP
EMBO J; 2020 Nov; 39(21):e106003. PubMed ID: 32946121
[TBL] [Abstract][Full Text] [Related]
4. NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX.
Ko KP; Jeong SI; Lim JS; Lee KW; Lee MG; Chi SG
Oncogene; 2020 Aug; 39(34):5675-5689. PubMed ID: 32690868
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor C-RASSF proteins.
Iwasa H; Hossain S; Hata Y
Cell Mol Life Sci; 2018 May; 75(10):1773-1787. PubMed ID: 29353317
[TBL] [Abstract][Full Text] [Related]
6. Identification of key target genes and pathways in laryngeal carcinoma.
Liu F; Du J; Liu J; Wen B
Oncol Lett; 2016 Aug; 12(2):1279-1286. PubMed ID: 27446427
[TBL] [Abstract][Full Text] [Related]
7. Ras signaling through RASSF proteins.
Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
[TBL] [Abstract][Full Text] [Related]
8. 12q14 Microdeletions: Additional Case Series with Confirmation of a Macrocephaly Region.
Mc Cormack A; Sharpe C; Gregersen N; Smith W; Hayes I; George AM; Love DR
Case Rep Genet; 2015; 2015():192071. PubMed ID: 26266063
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation status of Ras-association domain family members in pheochromocytoma.
Richter AM; Zimmermann T; Haag T; Walesch SK; Dammann RH
Front Endocrinol (Lausanne); 2015; 6():21. PubMed ID: 25750636
[TBL] [Abstract][Full Text] [Related]
10. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.
Guo W; Wang C; Guo Y; Shen S; Guo X; Kuang G; Dong Z
Clin Exp Metastasis; 2015 Jan; 32(1):83-98. PubMed ID: 25579665
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations of chromosomes, p53 and p16 genes in low- and high-grade bladder cancer.
Abat D; Demirhan O; Inandiklioglu N; Tunc E; Erdogan S; Tastemir D; Uslu IN; Tansug Z
Oncol Lett; 2014 Jul; 8(1):25-32. PubMed ID: 24959214
[TBL] [Abstract][Full Text] [Related]
12. NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis.
Liu LL; Zhang MF; Pan YH; Yun JP; Zhang CZ
Tumour Biol; 2014 Mar; 35(3):1763-74. PubMed ID: 24563371
[TBL] [Abstract][Full Text] [Related]
13. Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck.
Guo H; Liu H; Wei J; Li Y; Yu H; Guan X; Li-E W; Li G; Sturgis EM; Wei Q; Liu Z
Eur J Cancer; 2014 Feb; 50(3):582-92. PubMed ID: 24295637
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma.
Richter AM; Haag T; Walesch S; Herrmann-Trost P; Marsch WC; Kutzner H; Helmbold P; Dammann RH
Cancers (Basel); 2013 Nov; 5(4):1566-76. PubMed ID: 24252868
[TBL] [Abstract][Full Text] [Related]
15. Ras and rheb signaling in survival and cell death.
Ehrkamp A; Herrmann C; Stoll R; Heumann R
Cancers (Basel); 2013 May; 5(2):639-61. PubMed ID: 24216995
[TBL] [Abstract][Full Text] [Related]
16. Silencing of RASSF3 by DNA hypermethylation is associated with tumorigenesis in somatotroph adenomas.
Peng H; Liu H; Zhao S; Wu J; Fan J; Liao J
PLoS One; 2013; 8(3):e59024. PubMed ID: 23555615
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A and the rs2073498 Cancer Associated SNP.
Donninger H; Barnoud T; Nelson N; Kassler S; Clark J; Cummins TD; Powell DW; Nyante S; Millikan RC; Clark GJ
Front Oncol; 2011; 1():54. PubMed ID: 22649770
[TBL] [Abstract][Full Text] [Related]
18. Death pathways triggered by activated Ras in cancer cells.
Overmeyer JH; Maltese WA
Front Biosci (Landmark Ed); 2011 Jan; 16(5):1693-713. PubMed ID: 21196257
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.
Lee CK; Lee JH; Lee MG; Jeong SI; Ha TK; Kang MJ; Ryu BK; Hwangbo Y; Shim JJ; Jang JY; Lee KY; Kim HJ; Chi SG
BMC Cancer; 2010 Oct; 10():577. PubMed ID: 20969767
[TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences.
Schagdarsurengin U; Richter AM; Hornung J; Lange C; Steinmann K; Dammann RH
Mol Cancer; 2010 Sep; 9():264. PubMed ID: 20920251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
